Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
- Conditions
- Bronchial Cancer
- Interventions
- Diagnostic Test: ISET® - Isolation by Size of Tumor cells
- Registration Number
- NCT03328559
- Lead Sponsor
- Fondation Hôpital Saint-Joseph
- Brief Summary
The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated.
However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6
- patients with non-small cell lung cancer
- accepting participation
- refusing participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description advanced stage bronchial cancer ISET® - Isolation by Size of Tumor cells Patients locally moved forward or at a metastatic stage handled by chemotherapy early stage bronchial cancer ISET® - Isolation by Size of Tumor cells Early stage which can benefit from a surgical resection. A taking will be made in preoperative then in every consultation of follow-up after the intervention
- Primary Outcome Measures
Name Time Method numeration of CTC (circulant tumoral cell) Day 1
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Groupe Hospitalier Paris Saint Joseph
🇫🇷Paris, Ile-de-France, France